ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $26,019,760 | +3.6% | 1,601,216 | +17.9% | 0.10% | +5.4% |
Q1 2024 | $25,108,921 | -37.5% | 1,357,973 | +5.9% | 0.09% | -41.8% |
Q4 2023 | $40,144,962 | +84.4% | 1,282,177 | +22.8% | 0.16% | +47.7% |
Q3 2023 | $21,767,401 | +76.6% | 1,044,501 | +103.0% | 0.11% | +84.5% |
Q2 2023 | $12,324,047 | +203.3% | 514,574 | +138.3% | 0.06% | +190.0% |
Q1 2023 | $4,063,840 | -49.5% | 215,932 | -57.2% | 0.02% | -55.6% |
Q4 2022 | $8,041,256 | -30.2% | 505,104 | -28.3% | 0.04% | -27.4% |
Q3 2022 | $11,527,000 | -21.5% | 704,565 | -32.4% | 0.06% | -18.4% |
Q2 2022 | $14,685,000 | +42.8% | 1,042,255 | +145.4% | 0.08% | +31.0% |
Q1 2022 | $10,285,000 | +35.2% | 424,661 | +30.3% | 0.06% | +38.1% |
Q4 2021 | $7,607,000 | -40.5% | 325,913 | -57.7% | 0.04% | -48.8% |
Q3 2021 | $12,784,000 | -12.7% | 769,672 | +28.2% | 0.08% | -19.6% |
Q2 2021 | $14,645,000 | -11.2% | 600,432 | -6.1% | 0.10% | -15.0% |
Q1 2021 | $16,496,000 | +339.2% | 639,364 | +512.7% | 0.12% | +84.6% |
Q3 2019 | $3,756,000 | +1055.7% | 104,352 | +758.2% | 0.06% | +622.2% |
Q2 2019 | $325,000 | -64.2% | 12,160 | -64.0% | 0.01% | -66.7% |
Q1 2019 | $907,000 | – | 33,778 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |